Professor Marion Saville is an Anatomic Pathologist who has held the position of Executive Director at the Australian Centre for the Prevention of Cervical Cancer (ACPCC) since 2000. Marion has served on numerous cervical screening advisory committees in Australia, New Zealand and Ontario, leading the change from Pap based screening to more effective screening based on HPV testing and championing universal availability of self-collection. She currently chairs the working group to review Australia’s National Cervical Screening Program Guidelines and is co-PI on the Compass trial. Marion has focused on research and implementation projects demonstrating that it is possible to deliver high quality, acceptable cervical screening in a range of resource poor settings, collaborating with investigators in Malaysia, leading to the establishment of the ROSE Foundation where she is a founding Trustee. Marion is the ACPCC lead on the Department of Foreign Affairs and Trade funded Elimination Partnership in the Indo-Pacific for Cervical Cancer (EPICC). She was appointed as a member (AM) of the Order of Australia in 2020 for her significant service to women’s health through cervical screening initiatives.
BOARD APPOINTMENTS
- Member of the Global Initiative Against HPV and Cervical Cancer Advisory Board, Feb 2022 to present.
- Member of the Pacific Friends of Global Health Advisory Board, University of Melbourne, March 2020 to present.
- Trustee, the ROSE Foundation, Malaysia, July 2019 to present.
- Member of the International Board of Cytopathology 2010 to 2013.
- Member of the Budget and Finance Committee of the International Academy of Cytology, 2010 to 2013.
- Vice President of the Australian Society of Cytology, 2011 to 2013.
- President of the Australian Society of Cytology, October 2009 to 2011.
- Council Member of the International Board of Cytopathology, 2008 to 2010.
- President of the N.Z. Society of Cytology, 1995-1996.
 COMMITTEES
- Member of WHO , Virtual Technical Expert Panel on Selection And Prioritization Of Cancer Monitoring Framework Indicators – 2025
- Member of Ontario Cervical Screening Program’s Screening and Colposcopy Recommendations Expert Panel, May 2024 – June 2025
- Member of the WHO Living Systematic Review Guideline Development Group, December 2022 to present.
- Member of the International Taskforce on Cervical Cancer Elimination in The Commonwealth, March 2021 to present.
- Member of the Ontario Cervical Screening Program Expert Panel on Screening and Colposcopy Recommendations. Ontario Health, October 2020 to present.
- Co-Chair of the bi-annual Eliminating Cervical Cancer Conference (previously Preventing Cervical Cancer Conference), 2009, 2011, 2015, 2018, 2021, 2022, 2024.
- Member of the WHO Cervical Cancer Elimination Data Monitoring Group December 2019.
- Chair of the HPV Testing for Primary Screening Project Technical Reference Group, Ministry of Health, New Zealand, June 2016 to December 2021.
- Member of the Royal College of Pathologists of Australasia Cytopathology QAP Committee, 2001 to present.
- Member of the Royal College of Pathologists of Australasia Cytopathology Advisory Committee, 2001 to 2023
- Member of the Evolving Technologies Committee of the International Academy of Cytology, 1998.
- Member of the Membership Committee of the International Academy of Cytology, 1998.
- Member, local organising committee 40th Annual Scientific Meeting of The Royal College of Pathologists of Australasia, 1995.
- Chair of the local organising committee for the conjoint meeting of the Australian Society of Cytology and the New Zealand Society of Cytology, Auckland, 1995.
- Member Cervical Screening Recommendations Working Party, Ministry of Health, New Zealand, 1996 to 1997.
- Member local organising committee of the first NZ International Symposium on Gynaecologic Oncology, Auckland, 1995.
- Member Cervical Screening Advisory Liaison Committee, Ministry of Health, New Zealand, 1994 to 1996.
